Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy

American Journal of Kidney Diseases

Volumn 62, Issue 6, 2013, Pages 1223-1225

  Timmermans, Sjoerd A M E G ^a   Ayalon, Rivka ^b   Van Paassen, Pieter ^a   Beck, Laurence H ^b   Van Rie, Henk ^a   Wirtz, Joris J J M ^c   Verseput, Gaico H ^d   Frenken, Leon A ^d   Salant, David J ^b   Cohen Tervaert, Jan Willem ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c LAURENTIUS HOSPITAL   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LETTER; MALE; MALIGNANT NEOPLASTIC DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; OCCULT CANCER; PARANEOPLASTIC SYNDROME; PODOCYTE; PROTEINURIA; TUMOR REGRESSION; AGED; BLOOD; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PREDICTIVE VALUE; PROGNOSIS; WESTERN BLOTTING;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PODOCYTES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84888344712     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.07.019     Document Type: Letter

References (10)

1. R.J. Glassock The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey Am J Kidney Dis 56 1 2010 157 167
2. C.D. Brueggemeyer, and G. Ramirez Membranous nephropathy: a concern for malignancy Am J Kidney Dis 9 1 1987 23 26 (Pubitemid 17039815)
3. D.M. Burstein, S.M. Korbet, and M.M. Schwartz Membranous glomerulonephritis and malignancy Am J Kidney Dis 22 1 1993 5 10 (Pubitemid 23203492)
4. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group Chapter 7: idiopathic membranous nephropathy Kidney Int Suppl 2 2 2012 186 197
5. 2 receptor as target antigen in idiopathic membranous nephropathy N Engl J Med 361 1 2009 11 21
6. 2 receptor antibody in membranous nephropathy J Am Soc Nephrol 22 6 2011 1137 1143
7. C. Lefaucheur, B. Stengel, and D. Nochy Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association Kidney Int 70 8 2006 1510 1517 (Pubitemid 44527323)
8. R. Bjorneklett, B.E. Vikse, and E. Svarstad Long-term risk of cancer in membranous nephropathy patients Am J Kidney Dis 50 3 2007 396 403 (Pubitemid 47285451)
9. C. Murtas, M. Bruschi, and G. Candiano Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy Clin J Am Soc Nephrol 7 9 2012 1394 1400
10. 2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy Kidney Int 82 7 2012 797 804